[1] |
CAO Jun, ZHOU Yanlin, AI Zhengwen, LI Shigang.
Research progress on mechanism of action of Chaenomeles speciosa Nakai in the treatment of rheumatoid arthritis bone restruction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(3): 404-411.
|
[2] |
YANG Juanjuan, LI Haolin, YANG Tianning, CHENG Weigang, WANG Zhendong, JIN Fangmei, NIAN Fanghong, SU Xiaojun, WANG Jiaqiang, WANG Haiping, WANG Haidong.
Inhibition of Inflammation and Bone Destruction in mice with Collagen-induced Arthritis by Zushima Plaster
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(9): 979-987.
|
[3] |
GUAN Rui, YAO Jiashu, ZHAO Yeyu, ZHENG Jiannan, QI Qing, YU Jing, GAO Mingli.
Analysis and verification of the effect of Yi Qi Yang Yin decoction on rheumatoid arthritis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(1): 26-36.
|
[4] |
FAN Jie, JIN Yongming, JIANG Xiaolong, JIANG Guohua.
Molecular mechanism of lncRNA HOTAIR regulating miR-206 on the proliferation and apoptosis of rheumatoid arthritis synovial cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 736-742.
|
[5] |
WANG Tiefeng, SU Jie, WANG Weidong, XIA Rongshuang, LI Sifan, ZHU Wenrui, LOU Zhaohuan.
Mechanisms of Radix Tetrastigma on anti rheumatoid arthritis via regulating the balance of Th17/Treg
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 138-146.
|
[6] |
PAN Shu, WU Yijin, ZHANG Sasa, WANG Qihai, LUO Tingting, YIN Qin.
Pharmacokinetics of methotrexate mediated by organic anion transporter 3 in adjuvant induced arthritis rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 516-525.
|
[7] |
DU Juan, XU Lingyan, WU Wei, SHENG Qingqing, JIANG Zhenzhou, ZHANG Luyong, HUANG Xin.
Changes of transporters expression and activity in rheumatoid arthritis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(2): 223-229.
|
[8] |
CHEN Lanfang, QIANG Fuyong, XU Liang.
Short-term clinical observation of moderate to severe active rheumatoid arthritis treated with tocilizumab combined with disease modifying antirheumatic drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(12): 1386-1391.
|
[9] |
WU Jiaqi, YANG Qiaowen, CHEN Xiumin, HUANG Runyue, HUANG Qingchun, ZHAO Yue, WU Xiaodong.
Efficacy and safety of iguratimod combined with methotrexate in rheumatoid arthritis: A systematic review and Meta-analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(10): 1132-1140.
|
[10] |
SHEN Chen, LI Yunman, XIA Nian, XU Dan, HAN Dan, CHEN Shijie.
Research on the inhibition of Treg cells on MMP-9 in rheumatoid arthritis with acute cerebral ischemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(7): 831-840.
|
[11] |
GUO Huixia, TAO Mengqing, ZUO Jian, WANG Weiping.
Microemulsion as the drug delivery system improves inhibitory effects of α-mangostin on synovium
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(11): 1227-1231.
|
[12] |
YANG Hong, LIN Shan, YANG Hong, XIE Xiaowei, WANG Xin.
Effect of Ira Maude on VEGF and PEDF in patients with rheumatoid arthritis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(1): 68-71.
|
[13] |
LIU Dong-yang, SU Jing-mei, SONG Han-lin, CHEN Jia, LIU Yang, YAO Xue-ting, SONG Lin, JIANG Ji, HU Pei.
Pharmacokinetic modeling study on methotrexate and its active metabolites in rheumatoid arthritis patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(5): 571-577.
|
[14] |
GUO Ren, HUANG Pan-hao, LIU Zuo-liang.
Association between BSG gene polymorphism and rheumatoid arthritis susceptibility
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(7): 780-784.
|
[15] |
CAI Zhi-qi, ZHANG Yu, ZHANG Xue-zeng, SHEN Wei-gan.
Study on the effect of methotrexate on inflammatory cytokines and MAPK signal pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(12): 1347-1351.
|